Beyond Knowledge: A Multi-Level Behavioral and Health System Model Explaining Low Cervical Cancer Screening Uptake in Rural Northern Nigeria

Cervical cancer remains one of the leading causes of cancer-related morbidity and mortality among women in low- and middle-income countries, despite being preventable through vaccination and screening. Persistent infection with Human papillomavirus is responsible for nearly all cervical cancer cases globally. Recent evidence indicates that screening uptake in Nigeria remains critically low due to a complex interaction of socio-cultural, economic, behavioral, and health system barriers.
This study assessed determinants of cervical cancer screening uptake among women of reproductive age in Shira Local Government Area, Bauchi State, Nigeria, and proposed an Integrated Screening Uptake Model (ISUM). A community-based cross-sectional study involving 290 respondents was conducted using structured questionnaires. Data were analyzed using descriptive and inferential statistics.
Findings revealed poor knowledge (64.5%), negative attitude (73.1%), and low screening uptake (78.3%). No statistically significant association was observed between knowledge or attitude and uptake. Major barriers included poverty, long distance to facilities, out-of-pocket payment, and cultural beliefs.
The study concludes that low screening uptake is primarily driven by structural and systemic constraints rather than lack of awareness alone. Interventions should therefore adopt multi-level strategies addressing healthcare accessibility, affordability, gender norms, and culturally responsive service delivery.

Cervical cancer, HPV, screening uptake, Nigeria

1. World Health Organization. Cervical cancer. Geneva: WHO; 2024. [Google Scholar] [Crossref]

2. World Health Organization. Global strategy to accelerate the elimination of cervical cancer. Geneva: WHO; 2020. [Google Scholar] [Crossref]

3. World Health Organization. Comprehensive cervical cancer control: A guide to essential practice. 2nd ed. Geneva: WHO; 2021. [Google Scholar] [Crossref]

4. International Agency for Research on Cancer. GLOBOCAN 2022: Cervical Cancer Fact Sheet. Lyon: IARC; 2023. [Google Scholar] [Crossref]

5. World Health Organization. WHO guidelines for screening and treatment of cervical pre-cancer lesions. Geneva; 2021. [Google Scholar] [Crossref]

6. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between HPV and cervical cancer. J Clin Pathol. 2002;55(4):244–265. [Google Scholar] [Crossref]

7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of cervical cancer. J Pathol. 1999;189:12–19. [Google Scholar] [Crossref]

8. de Sanjosé S, Brotons M, Pavón MA. The natural history of HPV infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2–13. [Google Scholar] [Crossref]

9. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med. 2005;353:2101–2104. [Google Scholar] [Crossref]

10. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020. CA Cancer J Clin. 2021;71(3):209–249. [Google Scholar] [Crossref]

11. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions. Lancet Oncol. 2012;13(8):790–801. [Google Scholar] [Crossref]

12. Arbyn M, Weiderpass E, Bruni L, et al. Global burden of cervical cancer. Lancet Glob Health. 2020;8:e191–e203. [Google Scholar] [Crossref]

13. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for Africa. Int J Cancer. 2021;149:778–789. [Google Scholar] [Crossref]

14. Federal Ministry of Health Nigeria. National Cancer Control Plan 2018–2022. Abuja; 2018. [Google Scholar] [Crossref]

15. Ezechi OC, Gab-Okafor CV, Ostergren PO, et al. Willingness and acceptability of cervical screening in Nigeria. BMC Public Health. 2013;13:46. [Google Scholar] [Crossref]

16. Nwankwo KC, Aniebue UU, Aguwa EN, Anarado AN, Agunwah E. Knowledge and attitudes toward cervical cancer screening among Nigerian women. Afr J Reprod Health. 2011;15(3):43–49. [Google Scholar] [Crossref]

17. Hyacinth HI, Adekeye OA, Ibeh JN, Osoba T. Cervical cancer and Pap smear awareness in Nigeria. BMC Public Health. 2012;12:318. [Google Scholar] [Crossref]

18. Wright KO, Faseru B, Kuyinu YA, Faduyile FA. Awareness and uptake of screening among women in Lagos. J Community Health. 2014;39:413–420. [Google Scholar] [Crossref]

19. Ackerson K. Personal influences on Pap smear testing. J Obstet Gynecol Neonatal Nurs. 2010;39:50–60. [Google Scholar] [Crossref]

20. Wong LP, Wong YL, Low WY, Khoo EM, Shuib R. Knowledge and attitudes of Malaysian women. BMC Public Health. 2009;9:378. [Google Scholar] [Crossref]

21. Hoque E, Hoque M. Knowledge of cervical cancer among South African women. Afr Health Sci. 2009;9(1):23–27. [Google Scholar] [Crossref]

22. Getahun F, Mazengia F, Abuhay M, Birhanu Z. Screening uptake in Ethiopia. BMC Womens Health. 2013;13:2. [Google Scholar] [Crossref]

23. Black E, Hyslop F, Richmond R. Barriers to cervical screening. BMC Public Health. 2019;19:122. [Google Scholar] [Crossref]

24. Musa J, Achenbach CJ, O’Dwyer LC, et al. Cervical cancer screening in Nigeria: systematic review. J Glob Oncol. 2017;3(6):1–15. [Google Scholar] [Crossref]

25. Lim JNW, Ojo AA. Barriers to screening in Sub-Saharan Africa. Eur J Cancer Care. 2017;26:e12444. [Google Scholar] [Crossref]

26. Campos NG, Tsu V, Jeronimo J, et al. Evidence-based cervical cancer prevention. Lancet Glob Health. 2017;5:e954–e962. [Google Scholar] [Crossref]

27. Binka C, Nyarko SH, Doku DT. Barriers to screening among women in Ghana. PLoS One. 2019;14:e0212956. [Google Scholar] [Crossref]

28. Ebu NI, Mupepi SC, Siakwa MP, Sampselle CM. Knowledge and practice in Ghana. BMC Womens Health. 2015;15:92. [Google Scholar] [Crossref]

29. Rosser JI, Njoroge B, Huchko MJ. Knowledge and barriers in Kenya. J Low Genit Tract Dis. 2015;19(3):224–229. [Google Scholar] [Crossref]

30. Ndikom CM, Ofi BA. Awareness and screening in Ibadan. Afr J Med Med Sci. 2012;41:337–343. [Google Scholar] [Crossref]

31. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening. PLoS Med. 2008;5:e132. [Google Scholar] [Crossref]

32. Sankaranarayanan R, Ramadas K, Qiao YL. Managing cancer in developing countries. Lancet Oncol. 2014;15:e360–e372. [Google Scholar] [Crossref]

33. Denny L, Herrero R, Levin C, Kim JJ. Cervical cancer in low-resource settings. Vaccine. 2012;30:F71–F77. [Google Scholar] [Crossref]

34. Tsu VD, Pollack AE. Preventing cervical cancer in low-resource settings. Int J Gynaecol Obstet. 2005;89:S55–S59. [Google Scholar] [Crossref]

35. Rosenstock IM. Health Belief Model origins. Health Educ Monogr. 1974;2:328–335. [Google Scholar] [Crossref]

36. Glanz K, Rimer BK, Viswanath K. Health Behavior Theory. 5th ed. Jossey-Bass; 2015. [Google Scholar] [Crossref]

37. McLeroy KR, Bibeau D, Steckler A, Glanz K. Social ecological model. Health Educ Q. 1988;15:351–377. [Google Scholar] [Crossref]

38. Ajzen I. Theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211. [Google Scholar] [Crossref]

39. Ononokpono DN, Odimegwu CO. Determinants of health care utilization in Nigeria. BMC Health Serv Res. 2014;14:263. [Google Scholar] [Crossref]

40. Jacobs B, Ir P, Bigdeli M, et al. Addressing access barriers. Health Policy Plan. 2012;27:ii60–ii71. [Google Scholar] [Crossref]

41. Akinyemiju TF, et al. Socioeconomic inequalities in cancer outcomes. Lancet Glob Health. 2020. [Google Scholar] [Crossref]

42. Jedy-Agba E, et al. Cancer incidence in Nigeria. Cancer Epidemiol. 2021. [Google Scholar] [Crossref]

43. Ezeanolue EE, et al. Cervical cancer prevention in Nigeria. Vaccine. 2021. [Google Scholar] [Crossref]

44. Okunade KS. Cervical cancer burden in Nigeria. Ann Afr Med. 2020;19:1–7. [Google Scholar] [Crossref]

45. FMoH Nigeria & WHO. HPV vaccine introduction report. Abuja; 2023. [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar